| Title |
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|
|---|---|
| Published in |
New England Journal of Medicine, December 2020
|
| DOI | 10.1056/nejmoa2034577 |
| Pubmed ID | |
| Authors |
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Edson D Moreira, Cristiano Zerbini, Ruth Bailey, Kena A Swanson, Satrajit Roychoudhury, Kenneth Koury, Ping Li, Warren V Kalina, David Cooper, Robert W Frenck, Laura L Hammitt, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal, Dina B Tresnan, Susan Mather, Philip R Dormitzer, Uğur Şahin, Kathrin U Jansen, William C Gruber |
X Demographics
The data shown below were collected from the profiles of 39,557 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4980 | 13% |
| Japan | 1807 | 5% |
| United Kingdom | 1023 | 3% |
| Canada | 1008 | 3% |
| France | 999 | 3% |
| Spain | 644 | 2% |
| Germany | 578 | 1% |
| Malaysia | 453 | 1% |
| Turkey | 392 | <1% |
| Other | 4404 | 11% |
| Unknown | 23269 | 59% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 35898 | 91% |
| Scientists | 1847 | 5% |
| Practitioners (doctors, other healthcare professionals) | 1284 | 3% |
| Science communicators (journalists, bloggers, editors) | 405 | 1% |
| Unknown | 123 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 11,033 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 11033 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 1389 | 13% |
| Researcher | 1108 | 10% |
| Student > Ph. D. Student | 860 | 8% |
| Student > Master | 855 | 8% |
| Other | 656 | 6% |
| Other | 1634 | 15% |
| Unknown | 4531 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 2313 | 21% |
| Biochemistry, Genetics and Molecular Biology | 1013 | 9% |
| Immunology and Microbiology | 418 | 4% |
| Agricultural and Biological Sciences | 399 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 397 | 4% |
| Other | 1566 | 14% |
| Unknown | 4927 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 31696. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 April 2024.
All research outputs
#6
of 25,802,847 outputs
Outputs from New England Journal of Medicine
#1
of 32,692 outputs
Outputs of similar age
#2
of 530,026 outputs
Outputs of similar age from New England Journal of Medicine
#1
of 256 outputs
Altmetric has tracked 25,802,847 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,692 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 123.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 530,026 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 256 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.